Doximity, Inc. DOCS
We take great care to ensure that the data presented and summarized in this overview for Doximity, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding DOCS
View all-
Vanguard Group Inc Valley Forge, PA12.8MShares$601 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.8MShares$507 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL5.83MShares$274 Million1.19% of portfolio
-
Capital World Investors Los Angeles, CA5.38MShares$253 Million0.06% of portfolio
-
Clearbridge Investments, LLC New York, NY5.13MShares$241 Million0.3% of portfolio
-
State Street Corp Boston, MA4.03MShares$190 Million0.01% of portfolio
-
Baillie Gifford & CO3.85MShares$181 Million0.22% of portfolio
-
Geode Capital Management, LLC Boston, MA3.83MShares$180 Million0.02% of portfolio
-
Franklin Resources Inc San Mateo, CA3.36MShares$158 Million0.07% of portfolio
-
Loomis Sayles & CO L P2.48MShares$117 Million0.22% of portfolio
Latest Institutional Activity in DOCS
Top Purchases
Top Sells
About DOCS
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Insider Transactions at DOCS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 15
2025
|
Regina M. Benjamin Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,064
+37.9%
|
-
|
|
Nov 15
2025
|
Anna Bryson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,121
-1.38%
|
$250,929
$49.62 P/Share
|
|
Nov 15
2025
|
Jeffrey Tangney Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,005
-0.36%
|
$392,245
$49.62 P/Share
|
|
Nov 04
2025
|
Anna Bryson Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
22,868
+2.97%
|
-
|
|
Nov 03
2025
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,000
-9.16%
|
$132,000
$66.44 P/Share
|
|
Nov 03
2025
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,000
+8.39%
|
-
|
|
Oct 10
2025
|
Regina M. Benjamin Director |
SELL
Open market or private sale
|
Direct |
5,000
-20.13%
|
$350,000
$70.84 P/Share
|
|
Oct 10
2025
|
Regina M. Benjamin Director |
BUY
Conversion of derivative security
|
Direct |
5,000
+16.76%
|
-
|
|
Oct 01
2025
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,000
-9.16%
|
$140,000
$70.01 P/Share
|
|
Oct 01
2025
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,000
+8.39%
|
-
|
|
Sep 24
2025
|
Timothy S Cabral Director |
SELL
Open market or private sale
|
Direct |
20,000
-86.13%
|
$1,500,000
$75.0 P/Share
|
|
Sep 24
2025
|
Timothy S Cabral Director |
BUY
Conversion of derivative security
|
Direct |
20,000
+46.27%
|
-
|
|
Sep 12
2025
|
Regina M. Benjamin Director |
SELL
Open market or private sale
|
Direct |
5,000
-20.13%
|
$350,000
$70.5 P/Share
|
|
Sep 12
2025
|
Regina M. Benjamin Director |
BUY
Conversion of derivative security
|
Direct |
5,000
+16.76%
|
-
|
|
Sep 02
2025
|
Kira Scherer Wampler Director |
SELL
Open market or private sale
|
Direct |
2,000
-9.16%
|
$132,000
$66.57 P/Share
|
|
Sep 02
2025
|
Kira Scherer Wampler Director |
BUY
Conversion of derivative security
|
Direct |
2,000
+8.39%
|
-
|
|
Sep 02
2025
|
Timothy S Cabral Director |
SELL
Open market or private sale
|
Direct |
6,360
-66.38%
|
$419,760
$66.3 P/Share
|
|
Aug 28
2025
|
Regina M. Benjamin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,221
+13.97%
|
-
|
|
Aug 28
2025
|
Timothy S Cabral Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,221
+25.16%
|
-
|
|
Aug 28
2025
|
Kira Scherer Wampler Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,221
+13.97%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 215K shares |
|---|---|
| Conversion of derivative security | 3.68M shares |
| Open market or private sale | 1.42M shares |
|---|---|
| Other acquisition or disposition | 2.6M shares |
| Payment of exercise price or tax liability | 52.9K shares |
| Bona fide gift | 200K shares |